🇪🇪

Pharmaceutical Products from Estonia Tariff: 10% (2026)

Tariff Rate Breakdown

10%

EU Deal Ceiling

10%

Effective Rate

Among US trading partners for pharmaceutical products, Estonia plays a notable role, with approximately $1B in total bilateral trade.

Since July 1, 2026, imports of pharmaceutical products from Estonia trade under the EU-US deal's 15% all-inclusive ceiling — the MFN base does not stack on top, and products whose MFN rate is already 15% or higher pay MFN only. This succeeded the 10% Section 122 tariff (in effect February 24 through June 30, 2026), which had replaced the IEEPA reciprocal tariff struck down by the Supreme Court on February 20, 2026.

The 15% deal rate is durable: it stems from the EU-US agreement adopted by the Council of the EU on June 25, 2026, not from the 150-day Section 122 authority that expired July 24, 2026 for other countries. In exchange, the EU eliminated its duties on US industrial goods as of July 1, 2026.

Pharmaceutical Products (HTS Chapter 30) generally enter duty-free at the MFN level, so the EU deal's flat 15% is the entire duty burden. No additional Section 232 or Section 301 surcharges apply to most products in this category from Estonia.

Key products in HTS Chapter 30 imported from Estonia include Vaccines, Antibiotics, Insulin, Bandages, Diagnostic reagents, and Blood products.

Common Products in Chapter 30

VaccinesAntibioticsInsulinBandagesDiagnostic reagentsBlood productsPharmaceutical dosage formsFirst-aid kits

Calculate Your Import Duty

Use our tariff calculator to estimate the exact duty on your pharmaceutical products imports from Estonia.

Open Tariff Calculator

Frequently Asked Questions

What is the current tariff rate on pharmaceutical products from Estonia?

As of July 2026, pharmaceutical products from Estonia fall under the EU-US trade deal's 10% net of Column 1 for ordinary goods (15% only in lieu of Section 232 for autos, qualifying semiconductor articles, and drones) ceiling (effective July 1, 2026). Nothing stacks on top — goods with MFN rates below 15% pay 15% total, and goods with MFN rates of 15% or higher pay MFN only. The effective rate is about 15% on the most-affected products.

Will the tariff on pharmaceutical products from Estonia change?

Unlike the Section 301 forced-labor tariff on non-EU countries (which replaced the flat 10% Section 122 rate on July 24, 2026), the EU deal's 15% ceiling has no built-in expiration. The next scheduled change is September 1, 2026, when EU aircraft and aircraft parts, generic pharmaceuticals plus their ingredients and precursors, and unavailable natural resources revert to MFN-only rates.

How did 2026's tariff changes affect pharmaceutical products imports from Estonia?

Three regimes in one year: the Supreme Court struck down IEEPA reciprocal tariffs on February 20, 2026; a 10% Section 122 tariff bridged February 24 through June 30; and the EU-US trade deal's 10% net of Column 1 for ordinary goods (15% only in lieu of Section 232 for autos, qualifying semiconductor articles, and drones) ceiling took effect July 1, 2026. In exchange, the EU eliminated its duties on US industrial goods the same day.